SEARCH

SEARCH BY CITATION

References

  • Abdullah MF, Young T, Bitalo L, Coetzee N & Myers JE (2001) Public health lessons from a pilot programme to reduce mother-to-child transmission of HIV-1 in Khayelitsha. South African Medical Journal 81, 579583.
  • Abrams E, Myer L, Rosenfield A & El-Sadr W (2007) Prevention of Mother-to-Child Transmission services as a gateway to family-based HIV care and treatment in resource-limited settings: rationale and international experiences. American Journal of Obstetrics and Gynecology 197, S101S106.
  • Bolu O, Allread V, Creek TL et al. (2007) Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-child human immunodeficiency virus transmission settings in resource-limited countries. American Journal of Obstetrics and Gynecology 197, S83S89.
  • Boulle A, Bock P, Osler M et al. (2008) Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization 86, 678687.
  • Chasela C, Hudgens M, Jamieson D et al. (2009) Both maternal HAART and daily infant nevirapine are effective in reducing HIV-1 transmission during breastfeeding in a randomized trial in Malawi: 28 week results of the Breastfeeding, Antiretroviral and Nutrition (BAN) Study. 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town.
  • Cooper ER, Charurat M, Mofenson L et al. (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. Journal of Acquired Immune Deficiency Syndromes 29, 484494.
  • Downe S, Finlayson K, Walsh D & Lavender T (2009) ‘Weighing up and balancing out’: a meta-synthesis of barriers to antenatal care for marginalized women in high-income countries. British Journal of Obstetrics and Gynaecology 116, 518529.
  • Draper B & Abdullah F (2008) A review of the prevention of mother-to-child transmission programme of the Western Cape provincial government 2003-2004. South African Medical Journal 98, 431434.
  • El-Sadr WM & Abrams EJ (2007) Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings? AIDS 21, S65S70.
  • European Collaborative Study Group (2007) Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clinical Infectious Diseases 44, 16471656.
  • Hoffman R, Black V, Technau K et al. (2010) Impact of antiretroviral therapy regimen and duration of therapy on risk of mother-to-child HIV transmission in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndromes 54, 3541.
  • Jones TB (2008) Psychosocial dimensions of HIV infection in pregnancy. Clinical Obstetrics and Gynecology 51, 456466.
  • Kaplan R, Orrell C, Zwane E, Bekker LG & Wood R (2008) Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS 22, 16791681.
  • Kesho Bora Study Group (2009) Triple-antiretroviral (ARV) prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1 (MTCT): the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya and South Africa. 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town.
  • Killam W, Tambatamba BC, Chintu N et al. (2010) Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation. AIDS 24, 8591.
  • Makin JD, Forsyth BWC, VIsser MJ, Sikkema KJ, Neufeld S & Jeffery B (2008) Factors affecting disclosure in South African HIV-positive pregnant women. AIDS Patient Care and STDs 22, 907916.
  • McIntyre J (2010) Use of antiretrovirals during pregnancy and breastfeeding in low-income and middle-income countries. Current Opinion in HIV and AIDS 5, 4853.
  • Médicines Sans Frontières, Reproductive Health Research Unit, Southern African HIV Clinicians Society & Treatment Action Campaign (2009) Press release: “Time for task-shifting: 999 days to close the HIV/AIDS treatment gap”. 4th South African AIDS Conference, Durban.
  • Medley A, Garcia-Moreno C, McGill S & Maman S (2004) Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bulletin of the World Health Organization 82, 299307.
  • Mills E (2008) ‘Swimming in confusion’: a qualitative study of factors affecting uptake and adherence to antiretroviral treatment in South Africa. Working Paper No. 28. Centre for Social Science Research, University of Cape Town, Cape Town.
  • Ramdhial R & Ramkissoon A (2009) PMTCT: integration of HAART into public sector antenatal care services in a high prevalence HIV setting in South Africa. 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town.
  • Sanders LB (2008) Women’s voices: the lived experience of pregnancy and motherhood after diagnosis with HIV. Journal of the Association of Nurses in AIDS Care 19, 4757.
  • Schneider H, Blaauw D, Gilson L, Chabikuli N & Goudge J (2006) Health systems access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges. Reproductive Health Matters 14, 1223.
  • Shapiro R, Hughes M, Ogwu A et al. (2009) A randomized trial comparing highly active antiretroviral therapy regimens for virologic efficacy and the prevention of mother-to-child transmission among breastfeeding women in Botswana (The Mma Bana Study). 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town.
  • Simhkada B, Teijilingen ER, Porter M & Simkhada P (2008) Factors affecting the utilization of antenatal care in developing settings: a systematic review of the literature. Journal of Advanced Nursing 61, 244260.
  • Stringer EM, Chi BH, Chintu N et al. (2008) Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. Bulletin of the World Health Organization 86, 5762.
  • Taha TE, Kumwenda J, Cole SR et al. (2009) Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Journal of Infectious Diseases 200, 14901497.
  • Tlebere P, Jackson D, Loveday M et al. (2007) Community-based situation analysis of maternal and neonatal care in South Africa to explore factors that impact utilization of maternal health services. Journal of Midwifery and Women’s Health 52, 342350.
  • Toro PL, Katyal M, Carter RJ, Myer L, El-Sadr W & Nash D (2010) Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention. AIDS 24, 515524.
  • Van Coeverden de Groot HA (1993) Provision of a community perinatal service in a developing country. Australian and New Zealand Journal of Obstetrics and Gynaecology 33, 225229.
  • Van Coeverden de Groot HA, Davey DA & Howland RC (1982) The Peninsula Maternity and Neonatal Service: an urban community perinatal programme. South African Medical Journal 61, 3536.
  • World Health Organization (2009) Rapid Advice: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. WHO, Geneva.
  • World Health Organization, UNAIDS & UNICEF (2008) Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress Report. WHO, Geneva.
  • Zachariah R, Ford N, Philips M et al. (2009) Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 103, 549558.